1513.HK
1513.HK
CNE100001QV5
LIVZON PHARMA
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
19.68B EUR
21.2B EUR
24.35B EUR
Enterprise Value
16.06B EUR
17.22B EUR
18.43B EUR
Valuation Multiples
Trailing P/E
10.5x
11.49x
11.45x
Forward P/E
8.36x
--
--
Price to Sales
1.83x
1.93x
2.02x
Price to Book
1.26x
1.59x
1.68x
EV/Revenue
1.49x
1.57x
1.53x
EV/EBITDA
5.71x
6.37x
5.74x
Price to FCF (P/FCF)
9.34x
7.54x
9.48x
EV/FCF
7.62x
6.12x
7.17x
FCF Yield
10.71%
13.27%
10.55%
ende